A citation-based method for searching scientific literature

Patrick J Killela, Zachary J Reitman, Yuchen Jiao, Chetan Bettegowda, Nishant Agrawal, Luis A Diaz, Allan H Friedman, Henry Friedman, Gary L Gallia, Beppino C Giovanella, Arthur P Grollman, Tong-Chuan He, Yiping He, Ralph H Hruban, George I Jallo, Nils Mandahl, Alan K Meeker, Fredrik Mertens, George J Netto, B Ahmed Rasheed, Gregory J Riggins, Thomas A Rosenquist, Mark Schiffman, Ie-Ming Shih, Dan Theodorescu, Michael S Torbenson, Victor E Velculescu, Tian-Li Wang, Nicolas Wentzensen, Laura D Wood, Ming Zhang, Roger E McLendon, Darell D Bigner, Kenneth W Kinzler, Bert Vogelstein, Nickolas Papadopoulos, Hai Yan. Proc Natl Acad Sci U S A 2013
Times Cited: 841



Franklin W Huang, Eran Hodis, Mary Jue Xu, Gregory V Kryukov, Lynda Chin, Levi A Garraway. Science 2013
Times Cited: 1092




List of shared articles



Times cited

Glioblastoma and malignant melanoma: Serendipitous or anticipated association?
Kevin Yang, Thor D Stein, Bertrand R Huber, Emmett A Sartor, Jacob R Rachlin, Meera Mahalingam. Neuropathology 2021
1

A Pan-Cancer Study of Somatic TERT Promoter Mutations and Amplification in 30,773 Tumors Profiled by Clinical Genomic Sequencing.
Sounak Gupta, Chad M Vanderbilt, Yun-Te Lin, Jamal K Benhamida, Achim A Jungbluth, Satshil Rana, Amir Momeni-Boroujeni, Jason C Chang, Tiffany Mcfarlane, Paulo Salazar,[...]. J Mol Diagn 2021
1

Integrated analysis of telomerase enzymatic activity unravels an association with cancer stemness and proliferation.
Nighat Noureen, Shaofang Wu, Yingli Lv, Juechen Yang, W K Alfred Yung, Jonathan Gelfond, Xiaojing Wang, Dimpy Koul, Andrew Ludlow, Siyuan Zheng. Nat Commun 2021
2


Human telomerase is directly regulated by non-telomeric TRF2-G-quadruplex interaction.
Shalu Sharma, Ananda Kishore Mukherjee, Shuvra Shekhar Roy, Sulochana Bagri, Silje Lier, Meenakshi Verma, Antara Sengupta, Manish Kumar, Gaute Nesse, Deo Prakash Pandey,[...]. Cell Rep 2021
0

Human MettL3-MettL14 RNA adenine methyltransferase complex is active on double-stranded DNA containing lesions.
Dan Yu, John R Horton, Jie Yang, Taraneh Hajian, Masoud Vedadi, Cari A Sagum, Mark T Bedford, Robert M Blumenthal, Xing Zhang, Xiaodong Cheng. Nucleic Acids Res 2021
0

Frontiers in Bladder Cancer Genomic Research.
Yi Li, Lihui Sun, Xiangyang Guo, Na Mo, Jinku Zhang, Chong Li. Front Oncol 2021
0

Droplet digital PCR assay for detecting TERT promoter mutations in patients with glioma.
Jun-Ichi Adachi, Mitsuaki Shirahata, Tomonari Suzuki, Kazuhiko Mishima, Eita Uchida, Atsushi Sasaki, Ryo Nishikawa. Brain Tumor Pathol 2021
0

Telomerase as a Target for Therapeutic Cancer Vaccines and Considerations for Optimizing Their Clinical Potential.
Espen Basmo Ellingsen, Sara M Mangsbo, Eivind Hovig, Gustav Gaudernack. Front Immunol 2021
0

Cancer regulatory variation.
Rebecca C Hennessey, Kevin M Brown. Curr Opin Genet Dev 2021
0

Advances in Research of Adult Gliomas.
Alina Finch, Georgios Solomou, Victoria Wykes, Ute Pohl, Chiara Bardella, Colin Watts. Int J Mol Sci 2021
2

Human TERT promoter mutations as a prognostic biomarker in glioma.
Branka Powter, Sarah A Jeffreys, Heena Sareen, Adam Cooper, Daniel Brungs, Joseph Po, Tara Roberts, Eng-Siew Koh, Kieran F Scott, Mila Sajinovic,[...]. J Cancer Res Clin Oncol 2021
0

Telomerase reverse transcriptase promoter mutation- and O6-methylguanine DNA methyltransferase promoter methylation-mediated sensitivity to temozolomide in isocitrate dehydrogenase-wild-type glioblastoma: is there a link?
Dorothee Gramatzki, Jörg Felsberg, Bettina Hentschel, Marietta Wolter, Gabriele Schackert, Manfred Westphal, Luca Regli, Niklas Thon, Marcos Tatagiba, Wolfgang Wick,[...]. Eur J Cancer 2021
0

Cancer-specific loss of TERT activation sensitizes glioblastoma to DNA damage.
Alexandra M Amen, Christof Fellmann, Katarzyna M Soczek, Shawn M Ren, Rachel J Lew, Gavin J Knott, Jesslyn E Park, Andrew M McKinney, Andrew Mancini, Jennifer A Doudna,[...]. Proc Natl Acad Sci U S A 2021
0

Biology of Melanoma.
Stephen M Ostrowski, David E Fisher. Hematol Oncol Clin North Am 2021
0

TERT Promoter Alterations in Glioblastoma: A Systematic Review.
Nathalie Olympios, Vianney Gilard, Florent Marguet, Florian Clatot, Frédéric Di Fiore, Maxime Fontanilles. Cancers (Basel) 2021
0

Therapeutic targeting of FOS in mutant TERT cancers through removing TERT suppression of apoptosis via regulating survivin and TRAIL-R2.
Rengyun Liu, Jie Tan, Xiaopei Shen, Ke Jiang, Chaoqun Wang, Guangwu Zhu, Mingzhao Xing. Proc Natl Acad Sci U S A 2021
0

TERT promoter hotspot mutations and gene amplification in metaplastic breast cancer.
Edaise M da Silva, Pier Selenica, Mahsa Vahdatinia, Fresia Pareja, Arnaud Da Cruz Paula, Lorenzo Ferrando, Andrea M Gazzo, Higinio Dopeso, Dara S Ross, Ariya Bakhteri,[...]. NPJ Breast Cancer 2021
0

Establishment and Validation of the Detection of TERT Promoter Mutations by Human Gliomas U251 Cell Lines.
Huili Bai, Shunjie Bai, Xiaosong Li, Yangli Zhang, Ying Li, Fang He, Wei Cheng. Biomed Res Int 2021
0

TERT and its binding protein: overexpression of GABPA/B in high grade gliomas.
Efthymios Papazacharias, Saskia Kuhl, Gabriele Röhn, Lukas Görtz, Roland Goldbrunner, Marco Timmer. Oncotarget 2021
0

Non-coding driver mutations in human cancer.
Kerryn Elliott, Erik Larsson. Nat Rev Cancer 2021
0


Telomerase reverse transcriptase promoter mutations in cancers derived from multiple organ sites among middle eastern population.
Abdul K Siraj, Rong Bu, Kaleem Iqbal, Sandeep Kumar Parvathareddy, Nabil Siraj, Sarah Siraj, Mark Ranier F Diaz, Dionne Rae Rala, Allianah D Benito, Maria Angelita Sabido,[...]. Genomics 2020
1

Role of Heredity in Melanoma Susceptibility: A Primer for the Practicing Surgeon.
James F Abdo, Aayush Sharma, Rohit Sharma. Surg Clin North Am 2020
5

The transcription factor FLI1 promotes cancer progression by affecting cell cycle regulation.
Beiping Miao, Andrea S Bauer, Katrin Hufnagel, Yenan Wu, Marija Trajkovic-Arsic, Anna C Pirona, Nathalia Giese, Jussi Taipale, Jens T Siveke, Jörg D Hoheisel,[...]. Int J Cancer 2020
2

Telomere-related Markers for Cancer.
Xiaotian Yuan, Mingkai Dai, Dawei Xu. Curr Top Med Chem 2020
10

TERT promoter hotspot mutations and their relationship with TERT levels and telomere erosion in patients with head and neck squamous cell carcinoma.
Paolo Boscolo-Rizzo, Silvia Giunco, Enrica Rampazzo, Martina Brutti, Giacomo Spinato, Anna Menegaldo, Marco Stellin, Monica Mantovani, Luigia Bandolin, Marco Rossi,[...]. J Cancer Res Clin Oncol 2020
4

TERT Promoter Mutation as a Potential Predictive Biomarker in BCG-Treated Bladder Cancer Patients.
Rui Batista, Luís Lima, João Vinagre, Vasco Pinto, Joana Lyra, Valdemar Máximo, Lúcio Santos, Paula Soares. Int J Mol Sci 2020
12

Genomic footprints of activated telomere maintenance mechanisms in cancer.
Lina Sieverling, Chen Hong, Sandra D Koser, Philip Ginsbach, Kortine Kleinheinz, Barbara Hutter, Delia M Braun, Isidro Cortés-Ciriano, Ruibin Xi, Rolf Kabbe,[...]. Nat Commun 2020
21

The hTERT core promoter forms three parallel G-quadruplexes.
Robert C Monsen, Lynn DeLeeuw, William L Dean, Robert D Gray, T Michael Sabo, Srinivas Chakravarthy, Jonathan B Chaires, John O Trent. Nucleic Acids Res 2020
11

TERT promoter mutations and telomeres during tumorigenesis.
Franziska K Lorbeer, Dirk Hockemeyer. Curr Opin Genet Dev 2020
13

Frequency of somatic mutations in TERT promoter, TP53 and CTNNB1 genes in patients with hepatocellular carcinoma from Southern Italy.
Daniele Lombardo, Carlo Saitta, Domenico Giosa, Francesca Casuscelli Di Tocco, Cristina Musolino, Giuseppe Caminiti, Valeria Chines, Maria Stella Franzè, Angela Alibrandi, Giuseppe Navarra,[...]. Oncol Lett 2020
8

CDK1 dependent phosphorylation of hTERT contributes to cancer progression.
Mami Yasukawa, Yoshinari Ando, Taro Yamashita, Yoko Matsuda, Shisako Shoji, Masaki Suimye Morioka, Hideya Kawaji, Kumiko Shiozawa, Mitsuhiro Machitani, Takaya Abe,[...]. Nat Commun 2020
5

TERT, a promoter of CNS malignancies.
Bhuvic Patel, Rukayat Taiwo, Albert H Kim, Gavin P Dunn. Neurooncol Adv 2020
7

Regulation of human telomerase in homeostasis and disease.
Caitlin M Roake, Steven E Artandi. Nat Rev Mol Cell Biol 2020
42

Telomere Maintenance Mechanisms Define Clinical Outcome in High-Risk Neuroblastoma.
Balakrishna Koneru, Gonzalo Lopez, Ahsan Farooqi, Karina L Conkrite, Thinh H Nguyen, Shawn J Macha, Apexa Modi, Jo Lynne Rokita, Eduardo Urias, Ashly Hindle,[...]. Cancer Res 2020
11